Skip to main content
. Author manuscript; available in PMC: 2018 Feb 15.
Published in final edited form as: Biochem Pharmacol. 2016 Dec 8;126:51–68. doi: 10.1016/j.bcp.2016.12.003

Table 6.

Effect of Pachycladin A on the catalysis of ErbB kinases and EGFR mutant variants.

Kinase Mean inhibition at 10 μM (%)
EGFR (ERbB1) 91
HER2 (ERbB2) 15
HER4 (ErbB4) 16
EGFR L858R 98
EGFR L861Q 93
EGFR T790M 93
EGFR T790M L858F 7
EGFR d746-750